Ingel K. Demedts - Dept Resp Med, AZ Delta

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 65 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

An Acquired CCDC6:: RET Gene Fusion As Resistance Mechanism for Osimertinib in Exon 21 EGFR(L858R) -Mutated Non-Small Cell Lung Cancer and Its Successful Management with Osimertinib and Selpercatinib: a Case Report and Review of Literature

Maud Lormans, Peter Van Haecke,Ingel Demedts

Journal of Chemotherapy（2025）

Cited0Views0Bibtex

An Acquired CCDC6::RET Gene Fusion As Resistance Mechanism for Osimertinib in Exon 21 EGFR(L858R)-mutated Non-Small Cell Lung Cancer and Its Successful Management with Osimertinib and Selpercatinib: a Case Report and Review of Literature

Maud Lormans, Peter Van Haecke,Ingel Demedts

Journal of chemotherapy (Florence, Italy)pp.1-6, (2025)

Cited0Views0WOSBibtex

Maud Lormans, Peter Van Haecke,Ingel Demedts

JOURNAL OF CHEMOTHERAPY (2024)

Cited0Views0Bibtex

Preliminary Clinical Results of a Therapeutic Cancer Vaccine PDC*lung01 in Combination with Anti-Pd-1 in Patients (pts) with Stage IV NSCLC

Willemijn Theelen,Maurice Perol,Kristof Cuppens,Ingel Demedts,Frank Borm,Bonne Biesma,Els Wauters,Benoit Colinet, Eva-Lotte Buchmeier, Friederike Althoff,Elvire Pons-Tostivint,Charlotte Van de Kerkhove,Denis Moro-Sibilot,Anne Sibille,Sofie Derijcke,Marcin Skrzypski,Joel Plumas, Beatrice De Vos,Channa Debruyne,Frederique Cantero, Stefanie Adriaenssens, Florence Renard,Johan Vansteenkiste

CANCER RESEARCHno. 7 (2024)

Cited0Views0Bibtex

PDC*lung01: an Innovative Therapeutic Cancer Vaccine Induces Specific Immune Responses in Combination with Anti- PD-1 Treatment in Patients with Non-Small Cell Lung Cancer

Joel Plumas,Anne Sibille,Ingel Demedts,Elvire Pons-Tostivint,Charlotte Van de Kerkhove,Sofie Derijcke,Willemijn Theelen,Bonne Biesma,Frank Borm,Els Wauters, Mike Collodoro, Kays Al Badawy, Camille Duchayne,Channa Debruyne, Beatrice Devos,Benoit Colinet,Denis Moro-Sibilot,Maurice Perol, Eva-Lotte Buchmeier,Marcin Skrzypski,Kristof Cuppens,Johan Vansteenkiste

Cancer Researchno. 6_Supplement (2024): 1182-1182

Cited0Views0Bibtex

PDC*lung01: an Innovative Therapeutic Cancer Vaccine Induces Specific Immune Responses in Combination with Anti- PD-1 Treatment in Patients with Non-Small Cell Lung Cancer

Joël Plumas,Anne Sibille,Ingel Demedts,Elvire Pons‐Tostivint, C. Van De Kerkhove,Sofie Derijcke, Willemijn S.M.E. Theelen,Bonne Biesma,Frank Borm,Els Wauters, Mike Collodoro, Kays Al Badawy, Camille Duchayne,Channa Debruyne, Beatrice DeVos,Benoît Colinet, Denis Moro‐Sibilot, M. Pérol, E.L. Buchmeier,Marcin Skrzypski,Kristof Cuppens,Johan Vansteenkiste

Cancer Researchno. 6_Supplement (2024): 1182-1182

Cited0Views0Bibtex

PDC*lung01: an Innovative Therapeutic Cancer Vaccine Induces Specific Immune Responses in Combination with Anti- PD-1 Treatment in Patients with Non-Small Cell Lung Cancer

CANCER RESEARCHno. 6 (2024)

Cited0Views0Bibtex

Patient-centric Thresholding of Cobas® EGFR Mutation Test V2 for Surveillance of EGFR- Mutated Metastatic Non-Small Cell Lung Cancer

Jonas Claus,Dieter De Smet,Joke Breyne, Janusz Wesolowski,Ulrike Himpe,Ingel Demedts,Geert A. Martens

Scientific Reportsno. 1 (2024)

Cited0Views0WOSNATUREBibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn